Researchers at Amsterdam UMC have developed an algorithm that supports general practitioners in the early detection of lung cancer. Thanks to the use of artificial intelligence (AI), it is possible to identify patients with an increased risk up to four months earlier than with current methods. In doing so, they are taking an important step toward data-driven, personalized primary care.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…